Product Description: PLpro/RBD-IN-1 (compound 5) is a dual SARS-CoV-2 PLpro and spike protein RBD inhibitor with IC50s of 7.197 μM and 8.673 μM, respectively[1].
Applications: COVID-19-anti-virus
Formula: C13H10N4O
References: [1]Mohammed Salah Ayoup, et al. Repurposing 1,2,4-oxadiazoles as SARS-CoV-2 PLpro inhibitors and investigation of their possible viral entry blockade potential. Eur J Med Chem. 2023 Apr 5;252:115272.
CAS Number: 1282451-83-5
Molecular Weight: 238.24
Research Area: Infection
Solubility: 10 mM in DMSO
Target: SARS-CoV